Projects per year
Personal profile
Biography
A/Prof Phillip Parente trained at Monash University graduating with First Class Honours in 1993. He completed training in Medical Oncology 2001 and completed a 2year Fellowship in Immunology and Melanoma at Ludwig Institute for Cancer Research at Austin Health. Initially he worked as a Medical Oncologist at both Eastern Health and Austin Health. His current role is the Director of Cancer Services Eastern Health
His main areas of interest are Genitourinary Cancers, Lung Cancers and Melanoma and he is considered a clinical lead in these areas of oncology. With respect to oncology research he is principal investigator of numerous trials in his areas of interest. This has translated to numerous publications and presentations at local and international oncological conferences.
A/Prof Parente has professional interest in teaching and training. He is a senior member of the National Examining Panel for the Royal Australasian College of Physicians and past chair Advanced Trainee Committee Medical Oncology for the Royal Australasian College of Physicians. He is also the current Treasurer and Executive Committee Member of the Medical Oncology Group of Australia, (MOGA).
A/Prof Phillip Parente has completed a Master of Health and Medical Law in 2020 and currently completing a Master of Human Rights Law at the Faculty of Law, Melbourne University.
Clinical activities
Acting Director of Medical Oncology - Box Hill
Medical Oncologist
Specialist Advisory Committee Member - Medical Oncology - Royal College of Physicians, Lead in Assessment
Research interests
Melanoma, Lung Cancer, Urological Cancers.
Supervision interests
Director of Undergraduate 3rd Year Teaching - Box Hill Hospital
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Network
Projects
- 9 Finished
-
Avelumab Combined with Stereotactic Ablative Body Radiotherapy in Metastatic Castration-resistant Prostate Cancer: The Phase 2 ICE-PAC Clinical Trial
Kwan, E. M., Spain, L., Anton, A., Gan, C. L., Garrett, L., Chang, D., Liow, E., Bennett, C., Zheng, T., Yu, J., Dai, C., Du, P., Jia, S., Fettke, H., Abou-Seif, C., Kothari, G., Shaw, M., Parente, P., Pezaro, C., Tran, B., & 2 others , Mar 2022, In: European Urology. 81, 3, p. 253-262 10 p.Research output: Contribution to journal › Article › Research › peer-review
15 Citations (Scopus) -
Integrated Geriatric Assessment and Treatment Effectiveness (INTEGERATE) in older people with cancer starting systemic anticancer treatment in Australia: a multicentre, open-label, randomised controlled trial
Soo, W. K., King, M. T., Pope, A., Parente, P., Dārziņš, P. & Davis, I. D., Sep 2022, In: The Lancet Healthy Longevity. 3, 9, p. e617-e627 11 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access10 Citations (Scopus) -
Workforce challenges across Victorian medical oncology services
Collins, I. M., Blum, R., Segelov, E., Parente, P. & Underhill, C., Dec 2022, (Accepted/In press) In: Internal Medicine Journal. 5 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Independent prognostic impact of plasma NCOA2 alterations in metastatic castration-resistant prostate cancer
Fettke, H., Kwan, E. M., Bukczynska, P., Steen, J. A., Docanto, M., Ng, N., Parente, P., Mant, A., Foroughi, S., Pezaro, C., Hauser, C., Nguyen-Dumont, T., Southey, M. C. & Azad, A. A., 15 Sep 2021, In: The Prostate. 81, 13, p. 992-1001 10 p.Research output: Contribution to journal › Article › Research › peer-review
1 Citation (Scopus) -
Predictors of real-world utilisation of docetaxel combined with androgen deprivation therapy in metastatic hormone-sensitive prostate cancer
Azad, A. A., Tran, B., Davis, I. D., Parente, P., Evans, M., Wong, S., Brown, S., Evans, S., Millar, J., Murphy, D. G. & Papa, N., 12 Mar 2021, (Accepted/In press) In: Internal Medicine Journal. 20 p.Research output: Contribution to journal › Article › Research › peer-review
6 Citations (Scopus)